Cargando…
Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
SIMPLE SUMMARY: Cancer is a major global health concern, with the Mitogen-activated protein kinase (MAPK) pathway playing a crucial role in cancerous diseases. Indole alkaloids, such as vincristine and evodiamine, have been extensively studied for their potential in cancer treatment. These naturally...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670446/ https://www.ncbi.nlm.nih.gov/pubmed/38001572 http://dx.doi.org/10.3390/cancers15225311 |
_version_ | 1785139924993835008 |
---|---|
author | Al Amin, Md. Emran, Talha Bin Khan, Jishan Zehravi, Mehrukh Sharma, Indu Patil, Anasuya Gupta, Jeetendra Kumar Jeslin, D. Krishnan, Karthickeyan Das, Rajib Nainu, Firzan Ahmad, Irfan Wilairatana, Polrat |
author_facet | Al Amin, Md. Emran, Talha Bin Khan, Jishan Zehravi, Mehrukh Sharma, Indu Patil, Anasuya Gupta, Jeetendra Kumar Jeslin, D. Krishnan, Karthickeyan Das, Rajib Nainu, Firzan Ahmad, Irfan Wilairatana, Polrat |
author_sort | Al Amin, Md. |
collection | PubMed |
description | SIMPLE SUMMARY: Cancer is a major global health concern, with the Mitogen-activated protein kinase (MAPK) pathway playing a crucial role in cancerous diseases. Indole alkaloids, such as vincristine and evodiamine, have been extensively studied for their potential in cancer treatment. These naturally occurring indole alkaloids have strong anticancer properties, and research is ongoing to develop new anticancer small molecules. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment and focus on advancements in the role of indole alkaloids. The review also highlights clinical trials with indole alkaloids in cancer treatment. ABSTRACT: Cancer is the leading cause of morbidity and mortality in people throughout the world. There are many signaling pathways associated with cancerous diseases, from which the Mitogen-activated protein kinase (MAPK) pathway performs a significant role in this regard. Apoptosis and proliferation are correlated with MAPK signaling pathways. Plenty of experimental investigations were carried out to assess the role of indole alkaloids in MAPK-mediated cancerous diseases. Previous reports established that indole alkaloids, such as vincristine and evodiamine are useful small molecules in cancer treatment via the MAPK signaling system. Indole alkaloids have the anticancer potential through different pathways. Vincristine and evodiamine are naturally occurring indole alkaloids that have strong anticancer properties. Additionally, much research is ongoing or completed with molecules belonging to this group. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment. Additionally, we focused on the advancement in the role of indole alkaloids, with the intention of modifying the MAPK signaling pathways to investigate potential new anticancer small molecules. Furthermore, clinical trials with indole alkaloids in cancer treatment are also highlighted. |
format | Online Article Text |
id | pubmed-10670446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106704462023-11-07 Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment Al Amin, Md. Emran, Talha Bin Khan, Jishan Zehravi, Mehrukh Sharma, Indu Patil, Anasuya Gupta, Jeetendra Kumar Jeslin, D. Krishnan, Karthickeyan Das, Rajib Nainu, Firzan Ahmad, Irfan Wilairatana, Polrat Cancers (Basel) Review SIMPLE SUMMARY: Cancer is a major global health concern, with the Mitogen-activated protein kinase (MAPK) pathway playing a crucial role in cancerous diseases. Indole alkaloids, such as vincristine and evodiamine, have been extensively studied for their potential in cancer treatment. These naturally occurring indole alkaloids have strong anticancer properties, and research is ongoing to develop new anticancer small molecules. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment and focus on advancements in the role of indole alkaloids. The review also highlights clinical trials with indole alkaloids in cancer treatment. ABSTRACT: Cancer is the leading cause of morbidity and mortality in people throughout the world. There are many signaling pathways associated with cancerous diseases, from which the Mitogen-activated protein kinase (MAPK) pathway performs a significant role in this regard. Apoptosis and proliferation are correlated with MAPK signaling pathways. Plenty of experimental investigations were carried out to assess the role of indole alkaloids in MAPK-mediated cancerous diseases. Previous reports established that indole alkaloids, such as vincristine and evodiamine are useful small molecules in cancer treatment via the MAPK signaling system. Indole alkaloids have the anticancer potential through different pathways. Vincristine and evodiamine are naturally occurring indole alkaloids that have strong anticancer properties. Additionally, much research is ongoing or completed with molecules belonging to this group. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment. Additionally, we focused on the advancement in the role of indole alkaloids, with the intention of modifying the MAPK signaling pathways to investigate potential new anticancer small molecules. Furthermore, clinical trials with indole alkaloids in cancer treatment are also highlighted. MDPI 2023-11-07 /pmc/articles/PMC10670446/ /pubmed/38001572 http://dx.doi.org/10.3390/cancers15225311 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Al Amin, Md. Emran, Talha Bin Khan, Jishan Zehravi, Mehrukh Sharma, Indu Patil, Anasuya Gupta, Jeetendra Kumar Jeslin, D. Krishnan, Karthickeyan Das, Rajib Nainu, Firzan Ahmad, Irfan Wilairatana, Polrat Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment |
title | Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment |
title_full | Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment |
title_fullStr | Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment |
title_full_unstemmed | Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment |
title_short | Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment |
title_sort | research progress of indole alkaloids: targeting map kinase signaling pathways in cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670446/ https://www.ncbi.nlm.nih.gov/pubmed/38001572 http://dx.doi.org/10.3390/cancers15225311 |
work_keys_str_mv | AT alaminmd researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT emrantalhabin researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT khanjishan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT zehravimehrukh researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT sharmaindu researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT patilanasuya researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT guptajeetendrakumar researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT jeslind researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT krishnankarthickeyan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT dasrajib researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT nainufirzan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT ahmadirfan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment AT wilairatanapolrat researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment |